Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Gunsior

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biochemistry|January 21, 2004
Engineering p-hydroxyphenylpyruvate dioxygenase to a p-hydroxymandelate synthase and evidence for the proposed benzene oxide intermediate in homogentisate formationMichele Gunsior, Jacques Ravel, Gregory L Challis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 30, 2025
Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adultsWilliam Lumry, Michele Gunsior, Theodora Cohen, et al.
Chemistry & Biology|July 24, 2004
The biosynthetic gene cluster for a monocyclic beta-lactam antibiotic, nocardicin AMichele Gunsior, Steven D Breazeale, Amanda J Lind, et al.
RMD Open|August 4, 2023
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritisAlan Kivitz, Liangwei Wang, Ilias Alevizos, et al.
The Journal of Investigative Dermatology|March 11, 2006
The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturationRonald Wolf, Christopher J Voscopoulos, Peter C FitzGerald, et al.
Cancer Letters|January 13, 2009
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancerRonald Wolf, Christopher Voscopoulos, Jason Winston, et al.
Metabolic Engineering|February 10, 2006
Metabolic engineering of the E. coli L-phenylalanine pathway for the production of D-phenylglycine (D-Phg)Ulrike Müller, Friso van Assema, Michele Gunsior, et al.
British Journal of Pharmacology|October 25, 2019
The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeysSimone M Nicholson, Kerry A Casey, Michele Gunsior, et al.
The AAPS Journal|August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker AssessmentMitra Azadeh, Jeremy Good, Michele Gunsior, et al.
The AAPS Journal|January 13, 2026
Best practices in the application of parallelism for biomarker assay validationLindsay King, John Allinson, Lakshmi Amaravadi, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biochemistry|January 21, 2004
Engineering p-hydroxyphenylpyruvate dioxygenase to a p-hydroxymandelate synthase and evidence for the proposed benzene oxide intermediate in homogentisate formationMichele Gunsior, Jacques Ravel, Gregory L Challis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 30, 2025
Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adultsWilliam Lumry, Michele Gunsior, Theodora Cohen, et al.
Chemistry & Biology|July 24, 2004
The biosynthetic gene cluster for a monocyclic beta-lactam antibiotic, nocardicin AMichele Gunsior, Steven D Breazeale, Amanda J Lind, et al.
RMD Open|August 4, 2023
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritisAlan Kivitz, Liangwei Wang, Ilias Alevizos, et al.
The Journal of Investigative Dermatology|March 11, 2006
The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturationRonald Wolf, Christopher J Voscopoulos, Peter C FitzGerald, et al.
Cancer Letters|January 13, 2009
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancerRonald Wolf, Christopher Voscopoulos, Jason Winston, et al.
Metabolic Engineering|February 10, 2006
Metabolic engineering of the E. coli L-phenylalanine pathway for the production of D-phenylglycine (D-Phg)Ulrike Müller, Friso van Assema, Michele Gunsior, et al.
British Journal of Pharmacology|October 25, 2019
The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeysSimone M Nicholson, Kerry A Casey, Michele Gunsior, et al.
The AAPS Journal|August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker AssessmentMitra Azadeh, Jeremy Good, Michele Gunsior, et al.
The AAPS Journal|January 13, 2026
Best practices in the application of parallelism for biomarker assay validationLindsay King, John Allinson, Lakshmi Amaravadi, et al.
Pageof 3